跳至主要内容
临床试验/JPRN-UMIN000053279
JPRN-UMIN000053279尚未招募Unknown

Impact of systemic therapy on the serum vascular endothelial growth factor levels in patients with hepatocellular carcinoma after transarterial chemoembolization - Impact of systemic therapy on the serum vascular endothelial growth factor levels in patients with hepatocellular carcinoma after transarterial chemoembolization

Kitasato University School of Medicine0 个研究点目标入组 300 人开始时间: 2024年1月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • exclusion criterion 1. Child-Pugh C patients: 2. Patients with esophageal varices that may cause bleeding 3. Patients with gastrointestinal bleeding within 1 month 4. Patients who are pregnant, may be pregnant, or are breastfeeding 5. Patients with severe hypersensitivity to the components of this drug 6. Patients with severe heart failure or renal failure 7. Patients with malignant tumors other than hepatocellular carcinoma 8. Other patients unsuitable as subjects by the research director

研究者

发起方
Kitasato University School of Medicine

相似试验